,
Article History
Received: 4 July 2019
First Online: 13 April 2020
Disclosures
: Nita Ahuja reports grant funding from Cepheid and Astex, has served as a consultant to Ethicon, and has licensed methylation biomarkers to Cepheid. James C. Cusack reports grants from Lumicell Inc. outside the submitted work. Jesus Esquivel reports personal fees from Eight Medical. Garrett M. Nash reports non-financial support from Intuitive outside the submitted work. The remaining authors disclosed no conflicts of interest.